Exploratory
infection
INFECTION

To estimate the relative and absolute rate reduction of symptomatic culture-confirmed S. Typhi infection in TyphiBEV® unvaccinated participants in vaccine clusters compared to unvaccinated participants in non-vaccine clusters (indirect effect)To estimate the relative and absolute rate reduction of the incidence of hospitalised culture-confirmed S. Typhi infection in TyphiBEV®-vaccinated participants in vaccine clusters compared to unvaccinated participants in non-vaccine clusters